分层胆管癌:瘤微环境,分子驱动因素和新型免疫治疗方法
Cindy Xinqi Liu1,2, Carmen Chak-Lui Wong1,2,3,4
1Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong; Hong Kong, China.
Clinical and molecular hepatology
|October 14, 2025
概括
胆管癌 (CCA) 治疗受到瘤异质性的挑战. 根据TME和突变等因素对患者进行分层是有效的免疫疗法和个性化医学的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 胆管癌 (CCA) 是一种胆管癌,治疗选择有限.
- 目前先进的CCA治疗依赖于化疗,新兴的免疫疗法显示出适度的疗效.
- 在CCA中高的瘤间异质性阻碍了一种适合所有人的治疗方法.
研究的目的:
- 探索瘤间异质性在胆管癌的起源和影响.
- 确定导致CCA多样化的免疫微环境的因素.
- 强调在开发个性化免疫疗法时需要患者分层.
主要方法:
- 审查导致CCA瘤间异质性的因素.
- 分析这些因素如何影响瘤微环境 (TME).
- 讨论患者分层的潜在生物标志物.
主要成果:
- CCA的异质性来自于树皮细胞的丰富性,解剖位置,驱动突变,病因,TME组成和三级淋巴体结构 (TLS).
- 这些因素为每个患者创造了独特的免疫微环境.
- 特定因素显示出作为治疗选择生物标志物的潜力.
结论:
- 基于异质性的患者分层对于提高CCA治疗疗效至关重要.
- 了解个体瘤特征将指导最佳免疫疗法和组合疗法的选择.
- 个性化医疗方法对于CCA患者的更好的生存结果至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


